Gabrail Cancer Institute

Canton, Ohio 44718

0 studies enrolling now · 2 studies all time

What they study most

Head and Neck Cancer, Melanoma, Non Small Cell Lung Cancer, Small-cell Lung Cancer, Urothelial Carcinoma

Studies at this site

• Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer — Completed
• A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) — Stopped early